PTC Therapeutics logo

PTC Therapeutics

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.

4

Funding Rounds

$222.0m

Money raised

Overview

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.

Funding

Funding series

Funding Series Analysis

The company PTC Therapeutics has raised a total of $81.1m in funding over 4 rounds.

Key Insights:

  • PTC Therapeutics funding round, May 2013: $4.5m
  • PTC Therapeutics Series E round: $50m
  • PTC Therapeutics funding round, November 2005: $26.6m
  • PTC THERAPEUTICS, INC. funding round, May 2020: $140.95m
PTC Therapeutics logo
PTC Therapeutics funding round, May 2013 $4.5m
PTC Therapeutics logo
PTC Therapeutics Series E round $50m
PTC Therapeutics logo
PTC Therapeutics funding round, November 2005 $26.6m
PTC Therapeutics logo
PTC THERAPEUTICS, INC. funding round, May 2020 $140.95m

Subsidiaries

PTC Therapeutics operates through the following subsidiaries: